This approval is based on late-stage study data, which shows that treatment with AstraZeneca's (AZN) Imfinzi reduced the risk of recurrence by 32% in...

As the United States approaches its 2024 presidential election, the Chinese Communist Party (CPC) is meticulously evaluating its strategies to...

Announcing a new article publication for Zoonoses journal. No novel biomarkers are currently available for evaluating immune reconstitution among...

The approval is based on late-stage study data wherein treatment with J&J's (JNJ) Rybrevant plus Lazcluze cut the risk of disease progression or...

Ad hoc announcement pursuant to Art. 53 LR Nemluvio® (nemolizumab) is the first approved monoclonal antibody specifically inhibiting the signaling of...

Updated Date: Mon, 19 Aug 2024 00:00:00 EDT

Positive Phase 2a Fibromyalgia Results Deliver Pain Reduction in 100% of Patients, Strengthening IP Position and Clinical Trial Strategy Tryptamine...

Mthabisi Tshuma- revmmthiretshuma@gmail.com Some Zimbabweans in South Africa, Botswana, the United Kingdom, the United States of America (USA), and...

Mthabisi Tshuma- revmmthiretshuma@gmail.com Some Zimbabweans in South Africa, Botswana, the United Kingdom, the United States of America (USA), and...

SAN DIEGO, Aug. 19, 2024 /PRNewswire/ -- Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class,...